- Home
- CRGY vs HCM Comparison
CRGY vs HCM Comparison
Compare CRGY & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRGY
- HCM
- Stock Information
- Founded
- CRGY 1986
- HCM 2000
- Country
- CRGY United States
- HCM Hong Kong
- Employees
- CRGY N/A
- HCM N/A
- Industry
- CRGY Oil & Gas Production
- HCM Biotechnology: Pharmaceutical Preparations
- Sector
- CRGY Energy
- HCM Health Care
- Exchange
- CRGY Nasdaq
- HCM Nasdaq
- Market Cap
- CRGY 2.4B
- HCM 2.6B
- IPO Year
- CRGY N/A
- HCM N/A
- Fundamental
- Price
- CRGY $8.68
- HCM $17.93
- Analyst Decision
- CRGY Buy
- HCM
- Analyst Count
- CRGY 11
- HCM 0
- Target Price
- CRGY $15.89
- HCM N/A
- AVG Volume (30 Days)
- CRGY 5.5M
- HCM 55.8K
- Earning Date
- CRGY 11-03-2025
- HCM 08-07-2025
- Dividend Yield
- CRGY 5.54%
- HCM N/A
- EPS Growth
- CRGY N/A
- HCM N/A
- EPS
- CRGY 0.12
- HCM 0.53
- Revenue
- CRGY $3,468,319,000.00
- HCM $602,197,000.00
- Revenue This Year
- CRGY $26.44
- HCM $2.73
- Revenue Next Year
- CRGY N/A
- HCM $17.33
- P/E Ratio
- CRGY $74.35
- HCM $6.48
- Revenue Growth
- CRGY 32.84
- HCM N/A
- 52 Week Low
- CRGY $6.83
- HCM $11.51
- 52 Week High
- CRGY $16.94
- HCM $21.50
- Technical
- Relative Strength Index (RSI)
- CRGY 44.08
- HCM 65.46
- Support Level
- CRGY $8.22
- HCM $15.51
- Resistance Level
- CRGY $9.94
- HCM $16.28
- Average True Range (ATR)
- CRGY 0.46
- HCM 0.33
- MACD
- CRGY -0.10
- HCM 0.24
- Stochastic Oscillator
- CRGY 26.45
- HCM 90.00
About CRGY Crescent Energy Company
Crescent Energy Co is an independent energy company with a portfolio of assets in key basins across the lower 48 states. The company maintains a diverse portfolio of assets in key basins across the United States, including the Eagle Ford, Rockies, Barnett, Permian, and Mid-Con. It seeks to deliver attractive risk-adjusted investment returns and predictable cash flows across cycles with a focus on operated oil and gas assets complemented by non-operated assets, mineral and royalty interests, and midstream infrastructure.
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.